Benzocaine, eugenol for toothache OTC "feedback" meeting with NDMA set for June 25.
This article was originally published in The Tan Sheet
Executive Summary
BENZOCAINE, EUGENOL FOR TOOTHACHE OTC "FEEDBACK" MEETING TO BE HELD at FDA June 25 with the Nonprescription Drug Manufacturers Association. In an April 29 letter to FDA, the trade association asked the agency for "feedback" on the effectiveness of both ingredients for the relief of toothache. "Our concerns to discuss at the meeting include the status of benzocaine as an active ingredient for the temporary relief of toothache when the Final Monograph for Oral Health Care Products is established," the letter states. The safety of the ingredients is not at issue.